504 related articles for article (PubMed ID: 9482107)
1. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
2. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth.
Guerrero C; Martín-Encabo S; Fernández-Medarde A; Santos E
Oncogene; 2004 Jun; 23(28):4885-93. PubMed ID: 15077165
[TBL] [Abstract][Full Text] [Related]
3. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
4. [Activation of Rap1, antagonist to ras, by Crk-C3G].
Hattori S; Matsuda M
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1414-21. PubMed ID: 9309134
[TBL] [Abstract][Full Text] [Related]
5. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
6. Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor.
Whitehead I; Kirk H; Kay R
Oncogene; 1995 Feb; 10(4):713-21. PubMed ID: 7862449
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Drosophila C3G leads to cell fate changes and overproliferation during development, mediated by the RAS-MAPK pathway and RAP1.
Ishimaru S; Williams R; Clark E; Hanafusa H; Gaul U
EMBO J; 1999 Jan; 18(1):145-55. PubMed ID: 9878058
[TBL] [Abstract][Full Text] [Related]
8. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
9. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
10. Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor.
Chen SY; Huff SY; Lai CC; Der CJ; Powers S
Oncogene; 1994 Sep; 9(9):2691-8. PubMed ID: 8058333
[TBL] [Abstract][Full Text] [Related]
11. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
12. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.
York RD; Yao H; Dillon T; Ellig CL; Eckert SP; McCleskey EW; Stork PJ
Nature; 1998 Apr; 392(6676):622-6. PubMed ID: 9560161
[TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of C3G: an exchange factor that discriminates between Rap1 and Rap2 and is not inhibited by Rap1A(S17N).
van den Berghe N; Cool RH; Horn G; Wittinghofer A
Oncogene; 1997 Aug; 15(7):845-50. PubMed ID: 9266971
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
15. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
16. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.
Sakoda T; Kaibuchi K; Kishi K; Kishida S; Doi K; Hoshino M; Hattori S; Takai Y
Oncogene; 1992 Sep; 7(9):1705-11. PubMed ID: 1323817
[TBL] [Abstract][Full Text] [Related]
17. Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G.
Gotoh T; Hattori S; Nakamura S; Kitayama H; Noda M; Takai Y; Kaibuchi K; Matsui H; Hatase O; Takahashi H
Mol Cell Biol; 1995 Dec; 15(12):6746-53. PubMed ID: 8524240
[TBL] [Abstract][Full Text] [Related]
18. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.
Wolthuis RM; Bauer B; van 't Veer LJ; de Vries-Smits AM; Cool RH; Spaargaren M; Wittinghofer A; Burgering BM; Bos JL
Oncogene; 1996 Jul; 13(2):353-62. PubMed ID: 8710374
[TBL] [Abstract][Full Text] [Related]
19. The non-catalytic domain of ras-GAP inhibits transformation induced by G protein coupled receptors.
Xu N; McCormick F; Gutkind JS
Oncogene; 1994 Feb; 9(2):597-601. PubMed ID: 8290270
[TBL] [Abstract][Full Text] [Related]
20. Isoform-specific insertion near the Grb2-binding domain modulates the intrinsic guanine nucleotide exchange activity of hSos1.
Rojas JM; Subleski M; Coque JJ; Guerrero C; Saez R; Li BQ; Lopez E; Zarich N; Aroca P; Kamata T; Santos E
Oncogene; 1999 Mar; 18(9):1651-61. PubMed ID: 10208427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]